Citrus sinensis (Proprietary): A Comprehensive Reference
1. Identity and Nomenclature
Botanical name: Citrus sinensis (L.) Osbeck. The orange is the fruit of various citrus species in the family Rutaceae; it primarily refers to Citrus × sinensis, which is called the sweet orange, distinguished from related species such as sour orange (C. aurantium) and mandarin orange (C. reticulata). The species epithet sinensis reflects the plant's longstanding association with China, where it has been cultivated for millennia. Citrus sinensis (L.) Osbeck is the most common and important species among citrus.
Taxonomy and hybrid origin: The exact origin of Citrus sinensis is unknown, as it does not grow wild anywhere in the world; however, botanists believe it is a natural hybrid of the Pummelo (C. maxima) and the Mandarin (C. reticulata) and that it originated between the South-West of China and the Himalayas. For several years, the sweet orange tree was considered to be a form of the bitter orange tree (C. aurantium amara) and was thus referred to as C. aurantium var. sinensis.
Common names: Other common names include orange, Portugal orange, China orange, appelsin (Danish), apfelsine (German), naranjo (Spanish), and zhi shi (Chinese).
Varieties of botanical relevance: There are over 400 orange varieties, which can be divided into three groups: blonde or white oranges with normal fruits such as Valencia oranges from Spain; blood oranges with red pulp; the red color of blood oranges derives from the pigment anthocyanin. Red (or blood) orange [Citrus sinensis (L.) Osbeck] is a pigmented sweet orange found in eastern Sicily (southern Italy), California, and Spain. The term "Citrus sinensis (proprietary)" as it appears in supplement labeling typically refers to a standardized, proprietary extract derived from specific cultivars of C. sinensis—most notably the Sicilian "Moro" blood orange cultivar—processed and concentrated to retain defined levels of active phytochemicals. Such extracts are differentiated from raw juice or generic orange peel powder by their standardization to particular marker compounds and by patent protection held by the manufacturer.
Common preparations and dosage forms:
- Standardized dry extract (capsule/tablet): The most clinically studied proprietary form consists of a dried, standardized extract of C. sinensis Moro juice, supplied in capsules. The standardized extract, commercially known as Morosil®, was provided by Bionap S.R.L.; the supplement was in capsules, each containing 400 mg of standardized extract to be taken with water after breakfast.
- Cold-pressed peel essential oil: The oil is produced by pressing the fruit peel and fruit wall, which contain around 0.3 to 2 percent essential oil; the sweet orange oil has low viscosity and a color ranging from light to dark orange.
- Dried peel (herbal infusion/tea): Herbalists commonly use the dried peel in teas for its citrusy taste and to support healthy digestion.
- Fresh juice: The expressed juice of C. sinensis fruits, including specific blood orange cultivars, has been used in clinical investigations in volumes up to 500 mL per day.
- Tincture/fluid extract: Hydroalcoholic preparations of the peel have been employed in traditional herbal medicine systems.
2. Traditional and Historical Use
Citrus sinensis, commonly known as sweet orange, has a rich history of medicinal use dating back to ancient civilizations. Originating in Southeast Asia, its fruit, peel, and flowers were prized in traditional Chinese and Ayurvedic medicine.
2.1 East Asian Traditions
Citrus sinensis (L.) Osbeck is one of the extensively studied plants in the Rutaceae family; it is a popular and commonly used ingredient in Traditional Chinese Medicine, with preparations derived from peels, young fruit, mature fruit, flower, and other tissues. In Chinese medicine, the humble orange has a long history as a cooling agent for coughs, colds, and respiratory disorders. Dried sweet orange peel and dried ripe (and unripe) fruits of Seville (bitter) orange are ancient Chinese remedies; they are used for indigestion (the primary indication being to relieve heartburn), stubborn coughs, and anal and uterine prolapses, and also for treating shock in higher doses.
2.2 Traditional Uses Across Cultures
Orange probably originated from Southeast Asia and was cultivated in China by 2500 BC. According to historical sources, in 1493 Christopher Columbus carried orange seeds during his expedition to the Americas, and they eventually reached Haiti and the Caribbean; in the 16th century, Portuguese explorers introduced orange trees to the West; in 1513, Ponce de Leon introduced oranges to Florida; in 1450, Italian traders introduced orange trees to the Mediterranean region; in 800 AD, oranges were introduced to eastern Africa and the Middle East by Arab traders and distributed through trade routes.
Traditionally, C. sinensis has been used to treat conditions such as colic, constipation, cramps, diarrhea, bronchitis, tuberculosis, colds, coughs, obesity, menstruation disorders, angina, hypertension, anxiety, depression, and stress. For the treatment of tuberculosis, it is used in Mexican traditional medicine. For the treatment of angina, constipation, menstrual disorder, and hypertension, it is used in France.
In Europe, orange peels and blossoms became popular remedies during the Renaissance for treating nervous tension, palpitations, and mild insomnia due to their calming properties. Historically, Citrus sinensis was valued for its high vitamin C content, making it an essential remedy against scurvy among sailors and explorers during long sea voyages.
The aromatic orange peel was widely used to alleviate digestive disorders, reduce bloating, and stimulate appetite. The peel's bitter and enzymatic nature stimulates the production of digestive juices and eases bloating.
3. Key Constituents and Active Compounds
Studies' findings have shown that oranges are a good source of chemicals that could be used as functional additives in human health products and potential medication candidates; a large number of therapeutic potentials of C. sinensis have been reported, and they may be due to the presence of a variety of phytoconstituents.
3.1 Flavonoids (Flavanones)
The most abundant flavonoids in sweet orange (Citrus sinensis) fruit and juice are flavanone glycosides such as hesperidin; flavanones are known to be beneficial for human health, primarily through antioxidant activities. Hesperidin (hesperetin-7-rutinoside) is the dominant flavanone of C. sinensis. Hesperidin is the most important flavone in the orange that has been shown to reduce high blood pressure as well as cholesterol in animal studies. Flavonoids are probably the most important natural phenolic in C. sinensis (L.) Osbeck; these compounds possess biological activities including radical scavenging properties.
3.2 Polymethoxyflavones (PMFs)
Polymethoxyflavones (PMFs) have gained attention due to increasing evidence supporting their activities, including antioxidant, anti-inflammatory, anticancer, regulation of metabolic syndrome, and immune system effects. PMFs occur naturally in citrus peels and citrus-derived foods as well as in other plants; many in vitro and some in vivo studies have shown potentially relevant biological effects, including anticancer, anti-inflammatory, anti-atherosclerosis, and neuroprotective activities; these promising biological effects still require further research to establish their impact on human health. Key PMFs identified in C. sinensis include nobiletin, tangeretin, and sinensetin. Sinensetin, a polymethoxylated flavone abundant in citrus fruits, has been recognized for its broad biological activities and wide use in traditional medicine around the world.
3.3 Anthocyanins (Blood Orange Cultivars)
Anthocyanins and particularly cyanidin 3-glucoside, found in a large variety of fruits including Sicilian blood oranges, can help to counteract weight gain and to reduce body fat accumulation through the modulation of antioxidant, anti-inflammatory, and metabolic pathways. Moro orange is a rich source of active compounds such as hydroxycinnamic acid, flavone glycosides, and ascorbic acids, including anthocyanins with an average content of about 140 mg/L. Morosil contains high concentrations of anthocyanins, particularly cyanidin-3-glucoside and cyanidin-3-malonyl-glucoside, which appear to influence fat metabolism and adipose tissue accumulation.
3.4 Essential Oil Constituents
Approximately 1.5% essential oil is present in the orange fruit; d-limonene (approximately 90%), citral, sinesal, n-nonanal, n-decanal, n-dodecanal, geranyl acetate, anthranilic acid, citronellal, and linalyl acetate are present. The oil also contains aldehydes such as citral, citronellal, decanal, octanal, and small amounts of the esters neryl acetate and ethyl acetate. Linalool (4.4%) and myrcene (4.1%) are major antifungal constituents of Citrus sinensis.
3.5 Carotenoids
Citrus juice possesses bioactive compounds such as flavonoids, carotenoids, ascorbic acid, hydroxycinnamic acids, and anthocyanins. Carotenoids in C. sinensis include β-cryptoxanthin, violaxanthin, and antheraxanthin, though the specific profile varies substantially by cultivar.
3.6 Limonoids
Many phytochemicals, including limonoids, synephrine, hesperidin flavonoid, polyphenols, pectin, and sufficient folacin, calcium, potassium, thiamine, niacin, and magnesium, are also present in the orange. Limonoids are present in the orange and are proven to help fight a number of cancers like skin, lung, breast, stomach, and colon in preclinical studies.
3.7 Vitamins and Minerals
Citrus juices are excellent sources of vitamin C and contribute other key nutrients such as potassium, folate, magnesium, and vitamin A.
3.8 Furanocoumarins and Coumarins
Furanocoumarins were found to be more abundant (2–43 times) in the peel than in the pulp of citrus fruits. Two coumarins, isomeranzin and osthole, have been identified in a sweet orange (C. sinensis) cultivar, Changyecheng. The levels of furanocoumarins in C. sinensis are generally much lower than in grapefruit, though they are present and can have pharmacological relevance at the concentrations found in peel-concentrated extracts.
4. Mechanisms of Action
4.1 Antioxidant Activity
The antioxidant activity of C. sinensis (L.) Osbeck is related to the amount of phenolic compounds. These molecular events are orchestrated by an activation of several redox-dependent transcription factors, with nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) being key players; Nrf2 is responsible for maintaining the endocellular redox balance by activating the antioxidant response element (ARE)-dependent transcription of antioxidant defence enzymes such as heme oxygenase-1 (HO-1), superoxide dismutase-1 (SOD-1), and glutathione S-transferases (GSTs).
4.2 Anti-Inflammatory Action
Because of the presence of polymethoxyflavones, Citrus sinensis has anti-inflammatory activity. Special focus has been placed on structure-activity relationships (SAR), metabolic pathways, and cellular targets, including the PI3K/Akt/mTOR, Nrf2/Keap1, and NF-κB signaling axes for citrus-derived flavonoids. The NF-κB pathway modulation by citrus PMFs and flavanones results in downstream suppression of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6.
4.3 Lipid-Lowering Mechanisms
Bio-products based on citrus help in glycemic control, possibly by reducing resistin, an adipocytokine whose increase has been associated with insulin resistance, atherosclerosis, oxidative stress, and inflammation; all of these molecular events result in decreased lipogenesis and increased lipid oxidation, contributing to the control of the lipid profile.
4.4 Anti-Adipogenic and Weight-Related Mechanisms
A recent study showed that a red orange standardized extract is able to inhibit 3T3-L1 differentiation, by downregulating adipogenic genes and enzymes together with the modulation of adiponectin secretion and leptin release. Salamone and colleagues studied the effect of Moro juice on liver steatosis in mice with diet-induced obesity over a 12-week period; results revealed Moro juice exerted a metabolic hepatoprotective effect due to changes in the expression of several enzymes involved in lipid homeostasis.
4.5 Anxiolytic (Aromatherapy) Mechanisms
Inhalation of orange essential oil for 90 seconds has been observed to cause a significant decrease in oxyhemoglobin concentration in the right prefrontal cortex of the brain, which increases comfortable, relaxed, and natural feelings. The olfactory pathway is believed to mediate GABAergic modulation in limbic structures, though the precise neurochemical mechanism in humans has not been fully elucidated.
4.6 Antimicrobial Activity
The essential oil obtained from sweet orange peel has shown antibacterial and antifungal activities, being more effective against Gram-positive bacteria. An effective inhibitor of biodegrading and storage-related fungi is orange essential oil; hence it has antifungal properties.
5. Scientific Evidence by Area of Use
5.1 Cardiovascular Risk Factors and Lipid Metabolism
Hesperidin, the predominant flavanone of C. sinensis, has been the most intensively studied constituent in human clinical trials for cardiovascular benefits. Cardiovascular disease is a serious public health problem worldwide; the role of citrus flavanone hesperidin consumption on cardiovascular disease risk factors (CVDRFs) has been examined in many clinical trials, but conflicting results have been found; one study systematically evaluated the effects of hesperidin extracts or purified hesperidin on CVDRFs in humans with an updated meta-analysis of randomized controlled trials.
The meta-analysis included 12 trials with 589 participants and found evident effects of hesperidin on low-density lipoprotein cholesterol (WMD: −0.22 mmol/L; 95% CI: −0.33, −0.11 mmol/L) and total cholesterol (WMD: −0.20 mmol/L; 95% CI: −0.31, −0.08 mmol/L). Significant effects were also found for fasting blood glucose (WMD: −0.15 mg/dL; 95% CI: −0.29, −0.02 mg/dL), insulin-sensitivity index (WMD 0.06, 95% CI 0.01 to 0.10), intercellular adhesion molecule 1 (WMD: −13.60 ng/mL; 95% CI: −23.72, −3.48 ng/mL), vascular cell adhesion molecule 1 (WMD: −15.60 ng/mL; 95% CI: −30.13, −1.06 ng/mL), and C-reactive protein (WMD: −0.56 mg/L; 95% CI: −1.11, −0.01 mg/L), whereas no effects were found for other CVDRFs.
Meta-regression analysis showed that the efficacy of hesperidin in lowering triglyceride concentrations significantly increased with increasing doses (coefficient: −0.0007; P = 0.031) and duration (coefficient: −0.0563; P = 0.002). The findings demonstrate that hesperidin might be advantageous in improving numerous CVDRFs in humans, such as blood lipid concentrations, blood glucose control, and management of inflammatory indicators.
Evidence strength: Moderate. The meta-analysis was based on 12 RCTs with a combined 589 participants. Individual studies are generally small, and there is heterogeneity in hesperidin doses, extract forms, and study populations. Effects on blood pressure and body weight were not statistically significant across pooled analyses. In human studies, endothelial function improved with flavonoid consumption, whereas no conclusive results were observed for other biomarkers.
5.2 Blood Pressure
The active components in Citrus sinensis, particularly flavonoids such as hesperidin and naringenin, have demonstrated vascular-protective properties in preclinical and limited clinical studies; some small clinical trials and animal studies suggest that extracts from Citrus sinensis or its juice may lead to modest reductions in blood pressure. A randomized controlled trial published in the American Journal of Clinical Nutrition (Morand et al., 2011) found that daily consumption of orange juice rich in hesperidin improved endothelial function and slightly reduced diastolic blood pressure in healthy subjects.
Moro orange juice (MOJ) intake increased the production of short-chain fatty acids, especially propionic and isobutyric acids, and significantly improved cardiometabolic biomarkers such as blood pressure and plasma VCAM-1 levels in overweight women.
Evidence strength: Preliminary/weak. Evidence is not robust or sufficient to recommend Citrus sinensis as a primary or stand-alone therapy for hypertension; most studies use orange juice rather than proprietary extracts, and results are modest; larger, well-designed clinical trials are needed to confirm the efficacy and establish dosing guidelines.
5.3 Body Weight and Fat Mass Management
The most clinically studied proprietary preparation of C. sinensis for weight management is the standardized Moro blood orange extract. Native to Sicily and cultivated at the feet of the Etna volcano, the Moro orange cultivar Citrus sinensis Osbeck (Rutaceae) is the most highly pigmented red orange with high anthocyanin content.
In human studies carried out in overweight volunteers, after the consumption of 400 mg/day of Moro orange juice (Citrus sinensis (L.) Osbeck), particularly rich in anthocyanins, hydroxycinnamic acids, and flavone glycosides, a significant reduction in BMI, waist circumference, and hip circumference after 4-week and 12-week treatments, in comparison with the placebo group, was described.
A subsequent, larger confirmatory RCT was published in 2022. A total of 180 overweight (25 < BMI < 35 kg/m²) yet otherwise healthy female and male volunteers aged 20 to 65 years were recruited to take part in this 6-month study. The present study was a single-site, double-blind, randomized clinical trial assessing the effectiveness of a "Moro" orange standardized extract over a 6-month supplementation period. The study demonstrated that Moro blood orange standardized extract may be a safe and effective option for helping with weight loss when used in conjunction with diet and exercise.
As there had only been one human trial specifically on this extract of "Moro" orange cultivar, the aim of the second study was to further assess the effect of the standardized extract at the same dose on weight loss and on all safety markers of liver toxicity in healthy adult males and females aged between 20 and 65 years to better understand its action in conjunction with a calorie-controlled diet and exercise over a 6-month period.
Evidence to date has shown that blood oranges demonstrate potent antioxidant activity and cytoprotective effects that reflect their substantial role in preventing chronic pathological conditions such as cardiovascular diseases and in many forms of cancers.
Evidence strength: Preliminary to moderate. Only a small number of human RCTs have been conducted specifically on the proprietary Moro orange extract; the available trials report significant anthropometric improvements, but both trials were conducted in conjunction with calorie-controlled diet and exercise, making it difficult to isolate the extract's independent contribution. The total number of completed participants across both trials is limited, and additional independent replication is needed.
5.4 Anxiety and Psychological Effects (Aromatherapy)
Data show that Citrus aurantium or Citrus sinensis essential oils produce anxiolytic effects both in preclinical experiments and in different clinical conditions. Exposure to Citrus sinensis EO in clinical studies shows to be positive in reducing anxiety level in patients waiting for dental treatment as well as in healthy volunteers submitted to an anxiogenic situation.
A key human trial used the following design: The objective was to evaluate the potential anxiolytic effect of sweet orange (Citrus sinensis) aroma in healthy volunteers submitted to an anxiogenic situation; forty male volunteers were allocated to five different groups for the inhalation of sweet orange essential oil (test aroma: 2.5, 5, or 10 drops), tea tree essential oil (control aroma: 2.5 drops), or water (nonaromatic control: 2.5 drops); immediately after inhalation, each volunteer was submitted to a model of anxiety, the video-monitored version of the Stroop Color-Word Test (SCWT). The results gave scientific support to use sweet orange aroma as a tranquilizer by aromatherapists.
A systematic review of preclinical and clinical data found: Nine clinical studies fulfilled the criteria adopted for analysis. Volatile oil from C. sinensis, when administered orally, has been shown to have positive benefits on anxiety in clinical investigations, including in individuals with anxiety. C. sinensis Osbeck essential oil has been found to exert antidepressant effects, being suitable to treat minor stress.
Evidence strength: Preliminary. Most of the clinical studies are small and use inhalation as the route of administration. Standardization of aroma dosing is difficult, and many trials have methodological limitations. The body of evidence is suggestive but not conclusive for an anxiolytic effect.
5.5 Antimicrobial Activity
The essential oil obtained from sweet orange peel has shown antibacterial and antifungal activities, being more effective against Gram-positive bacteria. These findings are predominantly from in vitro studies using disc diffusion and minimum inhibitory concentration (MIC) methodologies. No robust human clinical trials have specifically tested proprietary C. sinensis extracts for antimicrobial endpoints in vivo.
5.6 Antidiabetic / Glycemic Effects
Citrus flavanoids play an important role in preventing progression of hyperglycemia, partly by binding to starch, increasing hepatic glycolysis and the glycogen concentration, and lowering hepatic gluconeogenesis. In animal models, nutraceutical diet alleviated serum glucose levels by 8.96% in a study; the conclusion was that inclusion of citrus peel bioflavonoids in dietary therapies is a promising strategy to modulate lipidemic and glycemic attributes without imparting any deleterious effect on hematological parameters.
Human clinical data for glycemic outcomes come primarily from the hesperidin meta-analysis described above, which found a modest but statistically significant reduction in fasting blood glucose. Data specifically for proprietary C. sinensis peel extracts in diabetic human populations are sparse. Evidence is preliminary and predominantly from animal or in vitro studies.
5.7 Gut Microbiota Modulation
One study investigated the effects of Moro orange (Citrus sinensis L. Osbeck) juice (MOJ) on gut microbiota composition and cardiometabolic biomarkers in overweight women; 12 overweight women (BMI from 25.0 to 29.9 kg/m²), aged 18–37 years, consumed 500 mL of MOJ every day for 4 weeks; researchers assessed gut microbiota composition, levels of short-chain fatty acids (SCFAs), cardiometabolic biomarkers, and insulin resistance (HOMA-IR) at baseline and after 2 and 4 weeks of MOJ intake; results suggested that MOJ intake affected the abundance of specific operational taxonomic units of the gut microbiota but did not significantly alter the diversity and general composition of the gut microbiota; however, MOJ intake increased the production of SCFAs, especially propionic and isobutyric acids, and significantly improved cardiometabolic biomarkers such as blood pressure and plasma VCAM-1 levels in the overweight women.
Evidence strength: Very preliminary. Only a single small pilot study (n = 12) has addressed this endpoint. Findings require replication in larger, adequately powered trials.
5.8 Antiproliferative / Anticancer Activity
Research on C. sinensis and cancer is predominantly preclinical. At concentrations of 82.6% and 73%, C. sinensis juice showed 100% antiproliferative activity against the cell lines K562 (human chronic myelogenous leukemia) and HL-60 (human leukemia); a concentration of 10% showed 90.5% antiproliferative activity against MCF-7 cells (human breast adenocarcinoma). These are in vitro data and cannot be directly extrapolated to clinical benefit in humans. Interest in the antineoplastic (anticancer) potential of orange peel ingredients has increased since 2020; although this category remains smaller than antioxidant or antimicrobial research, its growth highlights the increasing exploration of polyphenol-rich extracts as complementary strategies for disease prevention. No human clinical trials have assessed proprietary C. sinensis extracts as cancer treatments or preventive agents.
6. Body Systems and Health Areas Associated with Citrus sinensis
- Cardiovascular system: Lipid profile modulation (LDL-C, TC reduction), endothelial function improvement, VCAM-1 reduction, modest antihypertensive effects.
- Metabolic system: Glycemic control, insulin sensitivity, anti-adipogenic effects, weight and fat mass management.
- Gastrointestinal system: Digestive stimulant, carminative (reduction of bloating), gut microbiota modulation, pectin as prebiotic fiber.
- Immune and inflammatory system: Anti-inflammatory via NF-κB and Nrf2 modulation, antioxidant activity through phenolic and flavonoid scavenging mechanisms.
- Central nervous system / psychological: Anxiolytic effects via olfactory aromatherapy, antidepressant effects in minor stress (essential oil inhalation route).
- Antimicrobial defense: Antibacterial and antifungal activity of the essential oil (predominantly in vitro evidence).
- Integumentary system: Topical application of the essential oil; photodermatitis risk with furanocoumarin-containing expressed oils.
- Oncology (preclinical): Antiproliferative activity in leukemia, breast, and colon cell lines in vitro.
7. Dosage Forms and Reported Study Dosages
The following dosages are those reported in specific studies; they are not recommendations.
- Moro blood orange standardized extract (proprietary, e.g., Morosil®), oral capsule: 400 mg of Moro blood orange standardized extract supplementation in overweight yet otherwise healthy participants for 12 weeks induced a significant reduction in body weight, BMI, waist and hip circumference in comparison to the placebo group. The supplement was in capsules, each containing 400 mg of standardized extract, to be taken with water after breakfast.
- Moro orange juice, oral: In one study, 12 overweight women consumed 500 mL of Moro orange juice every day for 4 weeks.
- Sweet orange essential oil, inhalation (aromatherapy): In one human trial, groups inhaled sweet orange essential oil at 2.5, 5, or 10 drops as the test aroma. In animal studies, orange aroma was administered at 100, 200, or 400 µL for 5 minutes within a plexiglass chamber.
- Hesperidin extract or purified hesperidin, oral (cardiovascular studies): Because hesperidin was supplied at various doses and durations in the included trials, the correlation of changes in CVDRFs with hesperidin dosage (milligrams per day) and duration (weeks) were evaluated; no significant dose-response relationship was detected for most outcomes except triglycerides.
- Lyophilized C. sinensis juice (animal study, not human): Administration of lyophilized C. sinensis juice at a dose of 5 g/kg in aqueous vehicle in a volume of 0.5 mL/100 g body weight for 15 days in Wistar rats decreased plasma levels of cholesterol LDL. (This is a rodent dose and cannot be applied to human dosing.)
8. Safety Considerations and Drug Interactions
8.1 General Tolerability
The 2022 study demonstrated that Moro blood orange standardized extract may be a safe and effective option for helping with weight loss when used in conjunction with diet and exercise. In the clinical trials conducted with the proprietary Moro extract, no adverse effects on liver function were reported over the 6-month study period, based on monitored liver toxicity safety markers.
8.2 Phototoxicity (Essential Oil)
Furanocoumarins, also called furocoumarins or psoralens, can be found in high concentrations in bergamot, lime, and lemon oils and may cause phytophotodermatitis after subsequent exposure to UV light. The distilled oils are not phototoxic, while the expressed oils carry a low to moderate risk of phototoxicity due to the presence of furanocoumarins; in the case of applying expressed essential oils to the skin in a dose higher than the maximum dermal use level, it is recommended to avoid exposure to sunlight for at least 12 hours. Expressed sweet orange oil was neither irritating nor sensitizing to 25 volunteers when tested at 8 and 100%, whereas it caused sensitivity in 0.13% of total dermatitis patients when tested at 2%.
8.3 Drug Interactions — Orange Juice and Drug Bioavailability
Orange juice (Valencia), which is widely consumed, seems that it can considerably reduce the bioavailability of certain drugs; this interaction, as with many citrus fruits, could be due in part to modulation of intestinal wall transporters. Furanocoumarins in citrus fruit can cause adverse drug interactions; however, there are few reports on furanocoumarins and drug interactions in common edible citrus cultivars except grapefruit. The pulp of Xiyou, Hongyou, and Navel orange exhibited P450 inhibition, with 50% maximal inhibitory concentration (IC50) values of 0.63, 0.67, and 1.02 mg/mL, respectively.
It is important to distinguish C. sinensis from grapefruit (C. paradisi): grapefruit interactions are well known and documented; grapefruit contains flavonoids and furanocoumarins, which are responsible for various interactions with the cytochrome P450 enzyme system. The furanocoumarin burden in C. sinensis is substantially lower than in grapefruit, and interactions—while documented in vitro and for orange juice in pharmacokinetic studies—are generally considered less clinically severe than those associated with grapefruit. Nevertheless, peel-concentrated proprietary extracts of C. sinensis may contain higher furanocoumarin levels than the juice alone.
8.4 Cardiovascular Drug Interactions
Cardiovascular medications are indicated for and/or used to treat many different disorders, conditions, and diseases affecting the cardiovascular system, but in some cases could produce intensified effects, toxic levels, side effects, and/or adverse effects when combined with citrus constituents. Hesperidin's modest effects on blood pressure and lipid levels theoretically require monitoring when combined with antihypertensive or lipid-lowering pharmacotherapy, though direct clinical interaction data for C. sinensis-specific extracts are limited.
8.5 Allergenicity
Citrus allergy, though less common than allergy to some other fruits, does occur. Sensitization has been reported for both the pulp and the peel, and individuals with known citrus allergies should exercise caution with concentrated C. sinensis extracts. Cross-reactivity with other Rutaceae family members is documented in allergy literature.
8.6 Limitations of the Evidence Base
The overall evidence base for proprietary C. sinensis extracts as dietary supplements must be understood in context: there has only been one human trial specifically on the "Moro" orange cultivar standardized extract prior to the 2022 replication study, and the total body of evidence from RCTs, while growing, remains limited in scale and breadth. Many in vitro and some in vivo studies have shown potentially relevant biological effects of citrus polymethoxyflavones, including anticancer, anti-inflammatory, anti-atherosclerosis, and neuroprotective activities; these promising biological effects still require further research to establish their impact on human health. The label designation "proprietary" signals that the specific extract has been standardized and patent-protected, but does not by itself ensure superiority to non-proprietary preparations unless that specific form was used in the cited clinical trials.
References
Go back